Potential new diagnostic test and treatment for lung cancer
University of York spin out company, Cizzle Biotechnology, has secured venture capital funding from the White Rose Technology Seedcorn Fund to continue its development of a potential new diagnostic test and treatment for lung cancer.
This entry was posted on Tuesday, July 18th, 2006 at 9:46 am and is filed under Research. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.